MedTrace Logo

Parcel-guided rTMS for Major Depressive Disorder

NCT07287839 · Status: NOT_YET_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-18

No results posted yet for this study

Summary

Study comparing standard repetitive transcranial magnetic stimulation (rTMS) for Depression to a novel targeting approach using brain surface parcellation to locate a specific brain target.

Conditions

  • Treatment Resistant Depression (TRD)

Interventions

DEVICE

Accelerated rTMS

rTMS targeting will be done using the standard Beam-F3 targeting method. Treatment will be delivered in an accelerated schedule with 50 treatment session over 5 days.

DEVICE

Parcel-guided Accelerated rTMS

rTMS targeting will be done using brain surface parcellation. Treatment will be delivered in an accelerated schedule with 50 treatment sessions over 5 days.

Sponsors & Collaborators

  • Columbia University Irving Medical Center, New York, NY

    collaborator UNKNOWN

  • Soterix Medical

    lead INDUSTRY

Principal Investigators

  • Abhishek Datta, PhD · Soterix Medical, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2028-06-01
Completion
2028-06-15
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07287839 on ClinicalTrials.gov